{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:24:40Z","timestamp":1740176680698,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00261-021-03006-x","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T18:03:53Z","timestamp":1614967433000},"page":"3066-3074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CT imaging findings of lenvatinib-induced enteritis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-8900","authenticated-orcid":false,"given":"Ryo","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Tanishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moto","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Gonoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Amemiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"3006_CR1","doi-asserted-by":"crossref","unstructured":"Yamashita T, Kudo M, Ikeda K et al (2020) REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset. J Gastroenterol 55:113\u2013122","DOI":"10.1007\/s00535-019-01642-1"},{"key":"3006_CR2","doi-asserted-by":"crossref","unstructured":"Fleeman N, Houten R, Chaplin M et al (2019) A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC Cancer 19:1209","DOI":"10.1186\/s12885-019-6369-7"},{"key":"3006_CR3","doi-asserted-by":"crossref","unstructured":"Hiraoka A, Kumada T, Kariyama K et al (2019) Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis. Cancer Med 8:137\u2013146","DOI":"10.1002\/cam4.1909"},{"key":"3006_CR4","unstructured":"Food and Drug Administration (2018). Lenvatinib (Lenvima). Food and Drug Administration, Maryland, The United States. Available via https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/206947s007lbl.pdf. Accessed 2 Oct, 2020."},{"key":"3006_CR5","unstructured":"European Medicines Agency (2018). Lenvima-H-C-3727-II-0011-G : EPAR Assessment report. European Medicines Agency, Amsterdam, The Netherlands. Available via https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lenvima. Accessed 2 Oct, 2020."},{"key":"3006_CR6","doi-asserted-by":"crossref","unstructured":"Wittenberg J, Harisinghani MG, Jhaveri K, Varghese J, Mueller PR (2002) Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics 22:1093\u20131107","DOI":"10.1148\/radiographics.22.5.g02se201093"},{"key":"3006_CR7","doi-asserted-by":"crossref","unstructured":"Wiesner W, Mortel\u00e9 KJ, Ji H, Ros PR (2002) Normal colonic wall thickness at CT and its relation to colonic distension. J Comput Assist Tomogr 26:102\u2013106","DOI":"10.1097\/00004728-200201000-00015"},{"key":"3006_CR8","doi-asserted-by":"crossref","unstructured":"Koo TK, Li MY. (2016) A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 15(2): 155\u2013163.","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"3006_CR9","doi-asserted-by":"crossref","unstructured":"Cabanillas ME, Takahashi S (2019) Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer. Semin Oncol 46:57\u201364","DOI":"10.1053\/j.seminoncol.2018.11.004"},{"key":"3006_CR10","doi-asserted-by":"crossref","unstructured":"Honda S, Saito Y, Sawada K, Hasebe T, Nakajima S, Okumura T (2020) Repeated perforation of the gallbladder in a patient with hepatocellular carcinoma receiving lenvatinib. Intern Med 59:657\u2013662","DOI":"10.2169\/internalmedicine.3806-19"},{"key":"3006_CR11","doi-asserted-by":"crossref","unstructured":"Kawakami H, Kubota Y, Ban T, Shibata N, Hosokawa A (2018) Lenvatinib-induced acute pancreatitis associated with a pancreatic pseudocyst and splenic pseudoaneurysms. Pancreas 47:e34-e35","DOI":"10.1097\/MPA.0000000000001061"},{"key":"3006_CR12","doi-asserted-by":"crossref","unstructured":"Gunasekaran TS, Berman J, Gonzalez M (2000) Duodenojejunitis: Is it idiopathic or is it Henoch\u2013Sch\u00f6nlein purpura without the purpura? J Pediatr Gastroenterol Nutr 30:22\u201328","DOI":"10.1097\/00005176-200001000-00013"},{"key":"3006_CR13","doi-asserted-by":"crossref","unstructured":"Cornelissen L, Claus F, Wolter P et al (2015) Incidence of bowel wall oedema on computed tomography exams and association with diarrhoea in renal cell carcinoma patients treated with sunitinib. Eur Radiol 25:375\u2013379","DOI":"10.1007\/s00330-014-3389-1"},{"key":"3006_CR14","doi-asserted-by":"crossref","unstructured":"Verheul HM, Pinedo HM (2007) Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Nat Rev Cancer 7:475\u2013485","DOI":"10.1038\/nrc2152"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-021-03006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-021-03006-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-021-03006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T03:36:06Z","timestamp":1624246566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-021-03006-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3006"],"URL":"https:\/\/doi.org\/10.1007\/s00261-021-03006-x","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"type":"print","value":"2366-004X"},{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No complex statistical methods were necessary for this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}}]}}